Michigan Institute Of Research
Our Previous Work
Advancing Healthcare Together
At the Michigan Institute of Research (MIR), our mission to drive progress in healthcare is made possible through valuable partnerships with esteemed organizations and institutions. These collaborative relationships amplify our capacity to conduct groundbreaking research, discover innovative solutions, and improve patient care.
Previous Study Sponsors
Michigan Institute of Research
-
Sanofi: A global pharmaceutical leader, Sanofi collaborates with MIR to develop and advance cutting-edge medications and therapies, ultimately enhancing patient outcomes.
-
GSK (GlaxoSmithKline): GSK, a renowned pharmaceutical and healthcare company, partners with MIR to bring novel vaccines and healthcare solutions to the forefront of medical innovation.
-
Pfizer: As a global biopharmaceutical giant, Pfizer's collaboration with MIR drives research and development initiatives aimed at addressing pressing healthcare challenges.
-
NIH (National Institutes of Health): MIR is honored to partner with NIH, a prestigious federal agency dedicated to advancing medical research and public health. This partnership enables us to contribute to national healthcare initiatives.
-
CovarsaDX: Our collaboration with CovarsaDX enhances diagnostic capabilities, ensuring accurate and timely disease detection for improved patient care.
-
Shinogi: A leading global pharmaceutical company, Shinogi partners with MIR to explore novel treatment options and therapies for a wide range of medical conditions.
-
CUE: CUE's partnership with MIR empowers us to leverage cutting-edge diagnostic technologies to enhance patient diagnoses and outcomes.
-
Fortrea: Fortrea's collaboration with MIR strengthens our commitment to advancing healthcare through research and innovation.
-
Allucent: Our partnership with Allucent fuels progress in medical device development, enabling us to bring state-of-the-art technology to patient care.
-
Toolbox: Toolbox collaborates with MIR to provide essential tools and resources for streamlined research processes and optimal study outcomes.
-
MODERNA: MIR's partnership with Moderna, a pioneering biotechnology company, contributes to the development and testing of groundbreaking mRNA-based vaccines and therapies.
These valued partnerships are a testament to our commitment to excellence in research and healthcare. Together with our partners, we strive to push the boundaries of medical knowledge, pioneer transformative solutions, and make a meaningful impact on global health outcomes.
Join us in celebrating the power of collaboration as we work hand-in-hand with our trusted partners to shape the future of healthcare.